Are These 3 Popular Cannabis Stocks Overvalued Right Now?

popular cannabis stocks

The coronavirus pandemic has not been a particularly great time for most stocks, and in this regard, popular cannabis stocks are no exceptions either. Many pot stocks have recorded steep declines over the past months, and it has become abundantly clear that not all companies will end up as winners.

Some stocks have lost as much as 95% in recent months, and even then, there are certain popular cannabis stocks that are a bit overvalued. However, some cannabis stocks are still popular with investors, so it may be important to take a closer look at some of those to figure out why.

Here is a look at three popular cannabis stocks.

3 Popular Cannabis Stocks: Organigram Holdings (TSX:OGI) (NASDAQ:OGI)

popular cannabis stocks

There was a time when Organigram Holdings was regarded as one of the most efficient operators in the industry, and naturally, Organigram stock eventually became one of the more popular cannabis stocks on the market. However, it is necessary to keep in mind that companies need to generate meaningful growth as well if they are to be taken seriously, and in that regard, Organigram has been found wanting. In the fiscal second quarter, the company failed to generate any growth, and its losses widened as well.

While its adult-use sales rose 19% sequentially by C$2.96, wholesale sales dropped 40% by C$3.65. It is important to keep in mind that before Q1 2020, it was easier for cannabis companies to generate year-on-year growth. Cannabis was not yet legal in that time, so revenues were negligible, if any. However, the industry has grown significantly, and now there is a lot of competition among different players trying to grab a slice of the market.

>> 4 Hot Marijuana Stocks: Aphria Gains Momentum

For instance, erstwhile cannabis behemoth Aurora Cannabis has stated that it expects zero or negligible growth in the next quarter, which indicates the current state of the industry at large. Organigram will also need to pull up OGI stock if it is to generate growth.

Speaking of Aurora...

3 Popular Cannabis Stocks: Aurora Cannabis (TSX:ACB) (NYSE:ACB)

Pot Stocks under $5

A cannabis company that has spectacularly fallen from grace in recent times is Aurora Cannabis. Aurora stock has been beaten down considerably from being one of the more popular stocks in the sector; it is now one of the worst performers.

In 2019, the company was all set to emerge as the biggest cannabis producer in Canada and also seemed to be on track to sign many international supply agreements. As of this Monday, the stock was trading at only $0.75 a share. However, at a closer look, it becomes clear that even at that level, the stock may not actually be cheap.

The company has a market cap of $1 billion, and it has been diluting its stock in order to raise more cash. The number of outstanding shares has ballooned to 1.31 billion from only 16 million in a matter of six years. On top of that, Aurora is also facing an acute cash crunch, and recently, it raised $350 million in an at-the-market offering of its shares.

In addition to that, the company’s goodwill totals C$2.41 billion after the write-down of the C$762 million impairment charge in the second quarter. The company also halted construction of two of its projects in 2019. All things considered, at this state, Aurora's current stock price is hard to justify.

3 Popular Cannabis Stocks: Cronos Group (TSX:CRON) (NASDAQ:CRON)

popular cannabis stocks

Cronos Group is one of the popular cannabis stocks that might be on investor radars owing to its recent fall. The company ended 2019 with a cash balance of $1.5 billion, and the backing of tobacco giant Altria Group (NYSE:MO) is also a factor in its favor. While those are significant advantages, investors need to take a closer look at the company’s operations as well.

At this point, investors have paid $730 million for the company. In contrast, Cronos only generated $23.8 million worth of net sales last year. The losses amounted to $17.9 million. Peace Naturals is the only entity that gives Cronos a steady supply of product, and even that amounts to only 40,000 kilos a year. The company may have a lot of cash, and that might cushion the risks somewhat, but Cronos stock is still overvalued at a valuation of $720 million.

>> Read More Cultivation & Retail News

Featured image: Pixabay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.